Rolling Start-Up Key in Global Observational Cohort Study for Patients with Psoriasis
UBC was selected by a large biopharmaceutical company to manage a 5 year (2-year enrollment, 3-year follow-up) observational cohort study for patients with moderate-severe psoriasis who are initiating or switching to a new biologic.
Throughout the study, the team maintained study engagement with frequent and responsive communication with the sites and the sponsor country affiliates to alleviated the burden on site staff, subjects, and study team, resulting in a high compliance rate for Electronic Data Capture (EDC) / Electronic Patient Reported Outcomes (ePRO) completion.
Learn more about our Clinical Trial and Observational Studies capabilities today.